Back

EMPEROR-REDUCED Trial: main results.

29 August 2020 (18:31 - 18:50)
Organised by:
Congress Presentation Part of: New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients Treatment Open Access ESC Congress 2020

About the speaker

Photo
Professor Milton Packer

Baylor University Medical Center, Dallas (United States of America)

4 More presentations in this session

Presentation thumbnail
Introduction.
Professor J. Butler (Dallas, US)
Video
Presentation thumbnail
SGLT2 inhibitors in HFrEF, a meta-analytical approach.
Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Video
Presentation thumbnail
Panel discussion
Professor G. Filippatos (Athens, GR) Professor M. Packer (Dallas, US) Professor J. Butler (Dallas, US) Professor F. Zannad (Vandoeuvre-Les-Nancy, FR) Professor S. Anker (Berlin, DE)
Video
Presentation thumbnail
Conclusion.
Professor M. Packer (Dallas, US)
Video

Access the full session

Session thumbnail
New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients
Video

The Event

Event poster

ESC Congress 2020

29 August 2020 18:31 CET
You may be interested in
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Congress Session
Which device might help your HFpEF patient?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources